MGO One Seven’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,332
Closed -$221K 675
2021
Q3
$221K Sell
1,332
-647
-33% -$111K 0.03% 538
2021
Q2
$342K Sell
1,979
-1,025
-34% -$169K 0.05% 419
2021
Q1
$482K Hold
3,004
0.08% 304
2020
Q4
$505K Sell
3,004
-245
-8% -$39.7K 0.1% 254
2020
Q3
$511K Sell
3,249
-1,242
-28% -$203K 0.12% 230
2020
Q2
$753K Buy
4,491
+1,106
+33% +$174K 0.2% 134
2020
Q1
$443K Buy
3,385
+54
+2% +$7.69K 0.15% 197
2019
Q4
$495K Sell
3,331
-1,635
-33% -$225K 0.13% 220
2019
Q3
$615K Sell
4,966
-3,542
-42% -$472K 0.18% 154
2019
Q2
$1.2M Buy
8,508
+1,750
+26% +$241K 0.39% 66
2019
Q1
$1.02M Buy
6,758
+2,069
+44% +$298K 0.33% 83
2018
Q4
$582K Buy
+4,689
New +$641K 0.25% 92
2018
Q1
$35K Buy
261
+6
+2% +$819 0.02% 700
2017
Q4
$32K Buy
+255
New +$31.5K 0.01% 743

Other funds holding FBT

MGO One Seven's FBT Position: Q4 2021 in Review

MGO One Seven sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2021, closing a stake of 1,332 shares — an estimated $221K sold.

MGO One Seven first reported a position in FBT in Q4 2017 and held it in 14 quarters. The position peaked at $1.2M in Q2 2019. 247 funds tracked by Wall St. Rank hold FBT as of Q4 2021.

  • MGO One Seven reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2021 after selling out during the quarter.
  • MGO One Seven sold 1,332 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2021, an estimated $221K.
  • MGO One Seven first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2017 and held it in 14 quarters.
  • MGO One Seven's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.2M in Q2 2019.
  • 247 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2021.

Based on MGO One Seven's 13F filing for Q4 2021, filed 9 Feb 2022.